US 2025/0064912 A1 · VACCINES FOR NEISSERIA GONORRHOEAE

Abstract

A method for immunizing a subject in need thereof against Neisseria gonorrhoeaeby administering an immunogenic composition comprising meningococcal outer membrane vesicles (OMVs).

Claims16

Dependent claims

1-14. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

18/824,050Filed 4 Sep 2024

Priority

2 Sep 2016

Published

27 Feb 2025

Term ends

Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 39/095
Bacterial antigens: neisseria
A61K 39/116
Bacterial antigens: polyvalent bacterial antigens
A61K 39/39
Medicinal preparations containing antigens or antibodies: characterised by the immunostimulating additives, e.g. chemical adjuvants
A61K 47/646
Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is…: the…

Family

Application62/383,134Us provisional application · filed 2 Sep 2016

Application16/326,833Continuation · filed 20 Feb 2019

Application18/824,050Continuation

US 12,109,259 B2Related patent

US 2019/0282684 A1Published application

US 2025/0064912 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

A method for immunizing a subject in need thereof against Neisseria gonorrhoeaeby administering an immunogenic composition comprising meningococcal outer membrane vesicles (OMVs).

Vaccines for neisseria gonorrhoeae

Life of this patent

Abstract

Claims16

Vaccines for neisseria gonorrhoeae

Life of this patent

Abstract

Claims16